Bengaluru, India: For Ultrahuman, the journey toward building one of the world’s most advanced wearable ecosystems has never been linear. The Bengaluru-based health-tech company has now raised ₹100 crore ($11.2 million) in venture debt from Alteria Capital, giving it fresh fuel at a time when the brand is scaling globally while simultaneously navigating one of its toughest regulatory battles in the United States—its largest market.
The new capital will go toward expanding its product stack, strengthening software-led revenue, and bolstering its sports and research partnerships, the company said in a statement.
Founded by Mohit Kumar and Vatsal Singhal, Ultrahuman has grown into a deep-tech company with a strong global following. To date, it has raised over $71.2 million, including a $35 million Series B round led by Zomato CEO Deepinder Goyal. Investors Nexus Ventures and Blume Ventures remain among its largest external shareholders, while the founders jointly hold 28.9% of the company.
Financially, Ultrahuman’s momentum has been unmistakable. The company clocked ₹565 crore in operating revenue in FY25, with nearly 60% coming from the US. It also turned profitable, reporting ₹73 crore in net profit, marking a sharp turnaround from a ₹38 crore loss in FY24—a shift largely driven by scale and adoption in the US market.
But this growth spurt arrived alongside a serious challenge. In May, Finnish wearable maker Oura accused Ultrahuman of copying its ring design and patents, leading to a US import order blocking Ultrahuman rings from entering the country. Ultrahuman, in response, has filed its own case in Delhi, alleging that Oura copied its sensor technology and health features.
The company is now seeking clarity on whether devices produced at its Texas manufacturing facility fall outside the scope of the US import restriction—an answer that could determine how quickly it can normalize supply in its biggest market.
Despite the turbulence, Ultrahuman’s latest fundraise suggests investor confidence in the company’s long-term vision remains strong. For a brand built on science, data, and deep-tech engineering, the coming months will be crucial—not just for capital deployment, but for reclaiming momentum in a market that has shaped its global rise.
-By Muskan Dengra
